H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project. - Wikidata - awgldk - TriplyDB

H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project.

H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project.

http://www.wikidata.org/entity/Q30404999

about

Vaccines for preventing influenza in healthy adults Enhancing vaccine safety capacity globally: A lifecycle perspective International Consensus (ICON): allergic reactions to vaccines Near real-time vaccine safety surveillance using electronic health records-a systematic review of the application of statistical methods Phase 2 assessment of the safety and immunogenicity of two inactivated pandemic monovalent H1N1 vaccines in adults as a component of the U.S. pandemic preparedness plan in 2009.Surveillance systems and methods for monitoring the post-marketing safety of influenza vaccines at the Centers for Disease Control and Prevention.Guillain-Barré Syndrome, Influenza Vaccination, and Antecedent Respiratory and Gastrointestinal Infections: A Case-Centered Analysis in the Vaccine Safety Datalink, 2009-2011.A/H1N1 vaccine intentions in college students: an application of the theory of planned behavior.Responding to vaccine safety signals during pandemic influenza: a modeling study.Bell's palsy and influenza(H1N1)pdm09 containing vaccines: A self-controlled case series.[Guillain-Barré syndrome after exposure to influenza].Patterns in influenza antiviral medication use before and during the 2009 H1N1 pandemic, Vaccine Safety Datalink Project, 2000-2010.Safety of pandemic (H1N1) 2009 monovalent vaccines in taiwan: a self-controlled case series study.Orphan therapies: making best use of postmarket data.Prospective influenza vaccine safety surveillance using fresh data in the Sentinel System.A Synthesis of Current Surveillance Planning Methods for the Sequential Monitoring of Drug and Vaccine Adverse Effects Using Electronic Health Care Data.Challenges in the design and analysis of sequentially monitored postmarket safety surveillance evaluations using electronic observational health care data.Motor palsies of cranial nerves (excluding VII) after vaccination: reports to the US Vaccine Adverse Event Reporting System.Ontology-based combinatorial comparative analysis of adverse events associated with killed and live influenza vaccines.Triggers of hospitalization for venous thromboembolism.P value interpretations and considerations.Vaccination against infection in patients with multiple sclerosis.Assessing the safety of influenza vaccination in specific populations: children and the elderly.Vaccines and febrile seizures.Administering influenza vaccine to egg-allergic persons.Adapting group sequential methods to observational postlicensure vaccine safety surveillance: results of a pentavalent combination DTaP-IPV-Hib vaccine safety study.Quantifying the impact of time-varying baseline risk adjustment in the self-controlled risk interval design.Evaluating efficiency and statistical power of self-controlled case series and self-controlled risk interval designs in vaccine safety.Simulation study comparing exposure matching with regression adjustment in an observational safety setting with group sequential monitoring.Post licensure surveillance of influenza vaccines in the Vaccine Safety Datalink in the 2013-2014 and 2014-2015 seasons.Continuous sequential boundaries for vaccine safety surveillance.The "urban myth" of the association between neurological disorders and vaccinations.Minimizing signal detection time in postmarket sequential analysis: balancing positive predictive value and sensitivity.Absence of associations between influenza vaccines and increased risks of seizures, Guillain-Barré syndrome, encephalitis, or anaphylaxis in the 2012-2013 season.Lack of association of Guillain-Barré syndrome with vaccinations.Safety and immunogenicity of a seasonal trivalent inactivated split influenza vaccine: a phase I randomized clinical trial in healthy Serbian adults.Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel System.Epidemiology and Clinical Features of Guillain-Barre Syndrome in Isfahan, Iran.Enhanced Safety Surveillance of Seasonal Quadrivalent Influenza Vaccines in English Primary Care: Interim Analysis Sequential Statistical Methods for Prospective Postmarketing Safety Surveillance

P2860

Q24197955-90DCB6C3-C533-4777-8555-A80029737331 Q26782451-41F21549-2B93-4063-8134-F2D82FAAA32D Q27468685-DF3B326F-BE25-4093-98DD-FFE1C1DFDFF0 Q28075754-1026E635-CC63-4893-86CB-554026EB0F0C Q30224646-8491A865-F47F-47D6-9C93-F13203115B1E Q30249793-777F8C43-DA39-4ADA-8641-1CA3E5DCFC74 Q30351998-A9E6F955-949E-43E3-8044-4A3AD09BFB4F Q30361892-814AE0F2-A1AA-45CA-906A-2BB5FB297BE3 Q30370076-B3AE0C84-6E8D-418A-99F8-69BABAFCCC03 Q30401621-406215D9-6B82-478C-8E01-B8D1A73359FF Q30415924-2C851FB2-F060-4CC4-B685-BA5AA1182C29 Q30417851-C7AA16F2-F26B-4C03-8F7E-CD07D2F8C977 Q30428839-04DA99EB-A6B5-4D82-B484-FC6A1C1B5BB5 Q30836776-9A615917-EFC6-424D-90B7-C68DB4983F6D Q31024252-C5E02168-9478-4E00-AB08-E8C8385FA5EC Q31135365-598F81E0-8195-4880-B0FD-09E5CD104730 Q34133842-CCCFAC8A-59CF-4E9B-99C6-BC266815A9BE Q34290826-920AA7C7-CF26-4E82-B5EF-11EAC5783B93 Q34499848-47FD0F32-B3B0-4ECB-928D-BF18DA3C651E Q35929871-9E31DF39-69D5-4D39-BC33-EC955B300F2C Q37329406-F3C96E03-2EDB-4A80-A2C2-EE7C2DB215AD Q37978121-506B4639-F08E-45BC-9986-C08622AA0108 Q38045920-1B349653-2172-40D7-BFCA-559B40ABBB76 Q38132266-6CC300EA-A1D5-49DE-A0CC-0197F8FE8930 Q38222967-43BC030B-DFA0-4695-8B69-8C17364DC580 Q40261938-7A0BB3AA-6CE9-44CF-BF1A-FE13F907A18B Q40435214-8006F9F7-CB9E-48D1-9E3F-CB1E6CCC6DE2 Q40812015-08DA41C5-8837-4619-8005-F7392F57FFD3 Q41686667-2B05F944-6CA0-4218-B103-1D99BB182FA9 Q42081471-6B638240-586B-4D1B-A52E-9996A95B26B2 Q42221013-86D58B85-9108-4BFA-8531-8A552B7CFD5F Q43080823-0D6FD968-4784-4339-A585-609B910824FA Q44475855-0B07A8FB-696F-45BF-ACF5-98937F9B250D Q45162452-8BE1DAF9-F7F0-4ECB-93DB-1A2F94CE83A5 Q45873093-7BD34138-7D96-49FE-96D2-96F35F475F51 Q47193444-BACC608D-D219-4BE1-923A-431E3E9C304E Q48273359-74ADF494-80A2-448C-A360-2907C14C01BF Q55332829-87DF0D93-9ED4-4696-9954-62BA289F5419 Q57249841-4C4AFA46-E6A7-43CF-ACB5-B4C0E87D8E1D Q57590034-7EA720DB-950F-4A29-A243-F72B470027F4

P2860

H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project.

http://www.wikidata.org/entity/Q30404999

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project.

@ast

H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project.

@en

type

label

H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project.

@ast

H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project.

@en

prefLabel

H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project.

@ast

H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project.

@en

P1433

Q30404999-C387C210-2CE3-4CD9-8027-B7A9227E68C8

P1476

Q30404999-C7136EF5-B0ED-481B-BFCE-643CB6C27A03

P2093

Q30404999-283A946C-4A9D-4535-B2B1-757B920D2B10

Q30404999-3B2F8F48-0E5F-499B-AF31-24FE9FB7D96E

Q30404999-48EB3FDA-676C-4AD3-A1DB-DDBA0EDCF8B2

Q30404999-546D5842-2B4C-4F25-95BA-9DDA081F06A8

Q30404999-569A6F2F-5681-417F-89F7-1ADB4B6B1DE6

Q30404999-72A745A7-4432-4036-9765-967D7171F851

Q30404999-92BF7D99-D815-429F-8CCB-A50A77FEF519

Q30404999-A741E4B4-C799-4567-86F8-4D16BFCB2063

Q30404999-B119F9EF-A0D7-4586-A345-EBF9AB2B7D75

Q30404999-BEF3C2DD-51EB-4A93-BAB7-CD28EA817845

P304

Q30404999-4202F055-C94A-43DB-941A-1F3FB4281777

P31

Q30404999-2166AF28-8DC9-4981-9C70-A101980B46A2

P356

Q30404999-00060B7E-EDD6-4CD1-BE5D-52CFC6FDF902

P433

Q30404999-643C17D8-F746-44CA-B385-62E0EBFCA552

P478

Q30404999-22089AC2-86C9-4257-8CE3-A3352653942B

P50

Q30404999-1FCDAE78-4627-41EF-955C-75FA291FE1E0

Q30404999-ABD5EFD2-7D08-413C-B324-042021AC8848

Q30404999-C7EAD7ED-AF64-4EDA-B120-31F3D9CA0FBF

Q30404999-E0F94FD0-B22A-44F7-9A88-F239C88EF39C

Q30404999-E505781E-3D58-4117-88AA-CDD1835F78D1

Q30404999-FEB1041B-4E0D-42EC-BD2C-0FB34AE6D534

P577

Q30404999-153F749B-5DE5-4F8D-9C56-4ABEE5836C00

P698

Q30404999-CC583156-197E-4B16-A3CB-B36DDA95D39F

P356

J.AMEPRE.2011.04.004

P1433

American Journal of Preventive Medicine

P1476

H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project.

@en

P2093

Bruce H Fireman

http://www.w3.org/2001/XMLSchema#string

Claudia Vellozzi

http://www.w3.org/2001/XMLSchema#string

Eric S Weintraub

http://www.w3.org/2001/XMLSchema#string

Frank Destefano

http://www.w3.org/2001/XMLSchema#string

Grace M Lee

http://www.w3.org/2001/XMLSchema#string

James D Nordin

http://www.w3.org/2001/XMLSchema#string

Lingling Li

http://www.w3.org/2001/XMLSchema#string

Matthew F Daley

http://www.w3.org/2001/XMLSchema#string

Natalie McCarthy

http://www.w3.org/2001/XMLSchema#string

Roger Baxter

http://www.w3.org/2001/XMLSchema#string

P304

121-128

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AMEPRE.2011.04.004

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P50

Allison L. Naleway

Steven J Jacobsen

Stephanie Irving

Martin Kulldorff

Sharon K Greene

P577

2011-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21767718

http://www.w3.org/2001/XMLSchema#string